Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04526808 · ClinicalTrials.gov registry record · NA
Effects of Low FODMAP Diet on Leaky Gut
A NA study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT04526808 is a NA study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 14 participants.
The verdict
NCT04526808, a NA study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
The pathophysiology of Irritable bowel syndrome (IBS) is multifactorial involving complex interplay of altered intestinal permeability, mucosal immune activation, visceral hypersensitivity and gut dysbiosis. Although the exact triggers for these pathological changes in IBS are not clear but diet might play an important role. In fact, several studies have reported improvement in gastrointestinal symptoms on a diet low in FODMAPs (LFD) in patients with IBS, specifically in diarrhea predominant IBS (IBS-D). However, the mechanism of action of LFD is not well understood.
Interventions
- OTHER FODMAP diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2019-05-20 |
| Est. Completion | 2021-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04526808
The ClinicalTrials.gov registry entry for NCT04526808 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FODMAP diet is the first listed.
NCT04526808 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04526808 about?
NCT04526808 is a clinical study titled "Effects of Low FODMAP Diet on Leaky Gut". The pathophysiology of Irritable bowel syndrome (IBS) is multifactorial involving complex interplay of altered intestinal permeability, mucosal immune activation, visceral hypersensitivity and gut dysbiosis. Although the exact triggers for these pathological changes in IBS are not clear but diet mig...
What is the current status of trial NCT04526808?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2019-05-20. Estimated completion is 2021-06-01.
What interventions are being tested in trial NCT04526808?
The interventions under investigation include: FODMAP diet (OTHER).
Who is sponsoring clinical trial NCT04526808?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.